Aug 18, 2019 2:51 AM
BACK TO TOP
KSE 100
28,764.63
-664.44
(-2.26%)
KSE ALL
21,397.34
-370.35
(-1.70%)
KSE 30
13,406.78
-386.39
(-2.80%)
KMI 30
44,929.44
-1426.99
(-3.08%)
KMI ALL
13,453.11
-311.50
(-2.26%)
AGP Limited
PHARMACEUTICALS
Rs.51.47
-1.92
(-3.60%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Fri, Aug 16, 2019 5:00 PM
REG
FUT
ODL
Open
52.50
High
52.50
Low
51.06
Volume
2,500
CIRCUIT BREAKER
50.73 — 56.05
DAY RANGE
51.06 — 52.50
52-WEEK RANGE
51.06 — 101.00
Ask Price
51.47
Ask Volume
1,500
Bid Price
0.00
Bid Volume
0
LDCP
53.39
VAR
25.00
HAIRCUT
32.50
P/E Ratio (TTM)
11.34
1-Year Change *
-44.86%
YTD Change *
-41.13%
Open
56.09
High
56.09
Low
53.01
Close
53.01
Change
-0.82%
LDCP
53.45
Volume
477
Total Trades
7
CIRCUIT BREAKER
50.78 — 56.12
DAY RANGE
53.01 — 56.09
Ask Price
55.99
Ask Volume
1
Bid Price
51.00
Bid Volume
12
Market data powered by capitalstake.com. Provided by PSX.* Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

AGP Limited was incorporated as a public limited company in May 2014 under the repealed Companies Ordinance. The principal activities of the Company include import, marketing, export, dealership, distribution, wholesale and manufacturing of pharmaceutical products. The Company is subsidiary of OBS Pakistan and the Ultimate Parent Company is West End 16 Pte Limited - Singapore.

KEY PEOPLE
Mr Tariq Moinuddin KhanChairman
Ms Nusrat MunshiCEO
Mr.Adnan HusseiniCompany Secretary
ADDRESS

B-23-C, S.I.T.E, Karachi

WEBSITE

www.agp.com.pk

REGISTRAR

Central Depository Company of Pakistan Limited

AUDITOR

EY Ford Rhodes Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
14,411,600.00
Shares
280,000,000
Free Float
98,000,000
Free Float
35.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Aug 6, 2019Financial Results for the half year and quarter ended June 30, 2019 View   PDF
Apr 30, 2019Transmission of Quarterly Report for the period ended March 31, 2019 View   PDF
Apr 26, 2019Financial Results for the quarter ended March 31, 2019 View   PDF
Mar 6, 2019Financial Results for the year ended December 31, 2018 View   PDF
Mar 5, 2019Financial Results for the year ending December 31, 2018 View   PDF
Oct 31, 2018Transmission of Third Quarterly Report for the Period Ended September 30, 2018 View   PDF
Oct 26, 2018Financial Results for September 30, 2018 View   PDF
Aug 8, 2018Transmission of Half Yearly Report for the period ended June 30, 2018 View   PDF
Aug 2, 2018FINANCIAL RESULTS FOR THE HALF YEAR ENDED JUNE 30, 2018 View   PDF
Apr 27, 2018Financial Results for the Quarter Ended MARCH 31, 2018 View   PDF
DateTitleDocument
Aug 5, 2019Board Meeting in Progress View   PDF
Jul 29, 2019Board Meeting for the half year ended June 30, 2019 View   PDF
Apr 25, 2019Board Meeting in Progress View   PDF
Apr 18, 2019Board Meeting for the first quarter ended March 31, 2019 View   PDF
Mar 26, 2019Notice of 5th Annual General Meeting View   PDF
Feb 25, 2019Annual Board Meeting for the year ended December 31, 2018 View   PDF
Oct 25, 2018BOARD MEETING IN PROGRESS View   PDF
Oct 17, 2018Board Meeting View   PDF
Jul 26, 2018Board Meeting View   PDF
May 15, 2018Notice of Extraordinary General Meeting View   PDF
DateTitleDocument
Aug 1, 2019Corporate Briefing Session (CBS) View   PDF
May 16, 2019Material Information View   PDF
Mar 26, 2019Annual Report 2018 View   PDF
Mar 12, 2019Purchase of Nutraceutical Facility View   PDF
Jan 1, 2019Change of Company Secretary View   PDF
Jan 1, 2019Appointment of Company Secretary View   PDF
Aug 6, 2018Analyst Briefing View   PDF
Jul 10, 2018DISCLOSURE OF MATERIAL INFORMATION View   PDF
Jul 5, 2018DISCLOSURE OF MATERIAL INFORMATION View   PDF
Jun 19, 2018APPOINTMENT OF CHAIRMAN AND CHIEF EXECUTIVE OFFICER View   

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2018201720162015
Sales5,382,0554,724,9904,205,750
Profit after Taxation1,206,6901,233,9041,087,080
EPS4.314.413.88
Q2 2019Q1 2019Q3 2018Q2 2018
Sales1,558,5451,611,0091,168,4221,312,138
Profit after Taxation317,800425,297276,513284,598
EPS1.131.520.991.02
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

201820172016
Gross Profit Margin (%)56.5060.8358.49
Net Profit Margin (%)22.4226.1125.85
EPS Growth (%)(2.27)13.66
PEG(8.95)

Payouts

DateFinancial ResultsDetailsBook Closure
August 6, 2019 3:32 PM30/06/2019(HYR) 12.50%(i) (D) 23/08/2019 - 29/08/2019
April 27, 2018 10:50 AM31/03/2018(IQ) 12.50% (D) 25/05/2018 - 01/06/2018

Financial Reports